Report: The judge in Oklahoma admits that part of the $ 572 million fee for J & J in the case of opioids was miscalculated – asume tech

Advertisement

A judge in Oklahoma admitted that a miscalculation has led to his charging excessive fees to one of the world's largest drug companies in a case involving opioids.

The Associated Press said Tuesday that Cleveland County, Oklahoma, District Judge Thad Balkman has acknowledged the failure to charge a $ 107,000 charge for $ 107 million, for a premium of $ 572 million Johnson & Johnson, headquartered in New Brunswick, New Jersey, would have to pay the state.

Balkman told J & J to pay the $ 572 million in August after finding that the drug maker in Oklahoma had created a "public nuisance" by helping to fuel the opioid crisis. J & J appealed the verdict last month, stating that Balkman had made a miscalculation of the $ 107 million charge.

In its Tuesday report, the Associated Press reported that J & J lawyers are seeking an additional reduction in the amount. With the 107,000 US dollars, a program for the treatment of opioid-dependent born babies should be developed.

Regardless, the Wall Street Journal on Tuesday reported that the country's top three drug distributors McKesson, AmerisourceBergen and Cardinal Health were talking about settling opiate disputes worth $ 18 billion. Citing the persons familiar with the discussions, the newspaper reported that the amount was paid out over a period of 18 years, while J & J itself was being discussed for contributing additional money.

J & J, the aforementioned distributors and several other companies are facing more than 2,000 litigation by state and local authorities that their marketing of opioid painkillers has contributed to the nationwide epidemic of drug additions. The cases are part of a multiple district litigation (MDL) hearing this month in the US District Court for the Northern District of Ohio.

One of MDL's best-known companies, Purdue Pharma, filed for more than $ 10 billion in bankruptcy last month, although several attorneys general have criticized this move. Other MDL companies include other opioid manufacturers and retailers such as Walgreens.

Photo: MedCity News

(tagsToTranslate) Weight Loss (t) Obesity (t) Overweight (t) Diabetes (t) Massachusetts (t) Medical Devices (t) Obesity (t) Start-ups (t) Healthcare Innovation (t) Medical News (t) Medical News (t) San Francisco (t) Startups (t) Life Sciences (t) Accelerator (r) Rock Health (t) Startup Consultancy (t) Startup Financing (t) Patient Monitoring System (t) Motion Sensors (t) DC (t) Healthcare it (t) Washington (t) Foodborne Pathogens (t) Diagnostic Companies (t) Diagnostic Platforms (t) Minimally Invasive Surgery (t) Laser Surgery (t) Cambridge (t) Dealflow (t) Hospitals (t) Wellpoint (t) healthways (t) health and wellness (t) employee wellness programs (t) investments (t) wellness (t) medtronic (t) shanghai innovation center (t) china (t) r & d (t) china (t) mdt (t) minneapolis (t) minnesota (t) publics (t) twin cities (t) ulcerative colitis (t) abbott labs (t) humira (t) abbott labs (t) doctors (t) pharmaceuticals (t) skin diseases (t) pharmaceuticals (t) md Anderson cancer center (t) cancer (t) Texas (t) kidney Denervation (t) st. Jude Medical (t) st. electronic medical records (t) electronic health records (t) certified emr (t) certified emr (t) ehr (t) electronic health records (t) electronic medical records (t ) Advanced Cell Technology (t) Amyotrophic Lateral Sclerosis (t) Embryonic Stem Cells (t) Geron Corporation (t) Lou Gehrig

Related

Advertisement

Follow this link:
Report: The judge in Oklahoma admits that part of the $ 572 million fee for J & J in the case of opioids was miscalculated - asume tech